Hu S - Search Results

1

Prevalence and risk of cancer of thyroid incidentaloma identified by fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography.

Yang Z, Shi W, Zhu B, Hu S, Zhang Y, Wang M, Zhang J, Yao Z, Zhang Y. Yang Z, et al. Among authors: hu s. J Otolaryngol Head Neck Surg. 2012 Oct;41(5):327-33. J Otolaryngol Head Neck Surg. 2012. PMID: 23092835

2

Calcified metastases from ovarian carcinoma highlighted by F-18 FDG PET/CT: report of two cases.

Hu SL, Zhou ZR, Zhang YJ. Hu SL, et al. Abdom Imaging. 2012 Aug;37(4):675-9. doi: 10.1007/s00261-011-9800-3. Abdom Imaging. 2012. PMID: 21898082

3

The clinical value of fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography in postoperative patients with gastrointestinal mucinous adenocarcinoma.

Yang ZY, Hu SL, Shi W, Zhu BL, Xu JY, Zhang YJ. Yang ZY, et al. Nucl Med Commun. 2011 Nov;32(11):1018-25. doi: 10.1097/MNM.0b013e32834bbd22. Nucl Med Commun. 2011. PMID: 21956489

4

Clinical value of whole body fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography in the detection of metastatic bladder cancer.

Yang Z, Pan L, Cheng J, Hu S, Xu J, Ye D, Zhang Y. Yang Z, et al. Among authors: hu s. Int J Urol. 2012 Jul;19(7):639-44. doi: 10.1111/j.1442-2042.2012.02989.x. Epub 2012 Mar 27. Int J Urol. 2012. PMID: 22452420

5

Is whole-body fluorine-18 fluorodeoxyglucose PET/CT plus additional pelvic images (oral hydration-voiding-refilling) useful for detecting recurrent bladder cancer?

Yang Z, Cheng J, Pan L, Hu S, Xu J, Zhang Y, Wang M, Zhang J, Ye D, Zhang Y. Yang Z, et al. Among authors: hu s. Ann Nucl Med. 2012 Aug;26(7):571-7. doi: 10.1007/s12149-012-0614-3. Epub 2012 Jul 5. Ann Nucl Med. 2012. PMID: 22763630

6

Role of SUV(max) obtained by 18F-FDG PET/CT in patients with a solitary pancreatic lesion: predicting malignant potential and proliferation.

Hu SL, Yang ZY, Zhou ZR, Yu XJ, Ping B, Zhang YJ. Hu SL, et al. Nucl Med Commun. 2013 Jun;34(6):533-9. doi: 10.1097/MNM.0b013e328360668a. Nucl Med Commun. 2013. PMID: 23503000

7

18F-FLT PET/CT imaging is not competent for the pretreatment evaluation of metastatic gastric cancer: a comparison with 18F-FDG PET/CT imaging.

Zhou M, Wang C, Hu S, Zhang Y, Yao Z, Li J, Guo W, Zhang Y. Zhou M, et al. Among authors: hu s. Nucl Med Commun. 2013 Jul;34(7):694-700. doi: 10.1097/MNM.0b013e328361663a. Nucl Med Commun. 2013. PMID: 23604223

8

Can fluorine-18 fluoroestradiol positron emission tomography-computed tomography demonstrate the heterogeneity of breast cancer in vivo?

Yang Z, Sun Y, Zhang Y, Xue J, Wang M, Shi W, Zhu B, Hu S, Yao Z, Pan H, Zhang Y. Yang Z, et al. Among authors: hu s. Clin Breast Cancer. 2013 Oct;13(5):359-63. doi: 10.1016/j.clbc.2013.02.012. Epub 2013 Jun 17. Clin Breast Cancer. 2013. PMID: 23787040

9

Pathology-confirmed granuloma mimicking liver metastasis of breast cancer.

Li T, Fan M, Shui R, Hu S, Zhang Y, Hu X. Li T, et al. Among authors: hu s, hu x. Int J Biol Markers. 2014 Mar 24;29(1):e93-7. doi: 10.5301/jbm.5000074. Int J Biol Markers. 2014. PMID: 24474453 Free article.

10

Is 18F-FDG PET/CT more reliable than 99mTc-MDP planar bone scintigraphy in detecting bone metastasis in nasopharyngeal carcinoma?

Yang Z, Zhang Y, Shi W, Zhu B, Hu S, Yao Z, Pan H, Hu C, Zhang Y, Li D. Yang Z, et al. Among authors: hu s, hu c. Ann Nucl Med. 2014 Jun;28(5):411-6. doi: 10.1007/s12149-014-0831-z. Epub 2014 Mar 8. Ann Nucl Med. 2014. PMID: 24610681

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

18,769 results

Search Page

Filters